ProCE Banner Activity

ZeNix: Pretomanid, Bedaquiline, and Varied Doses and Durations of Linezolid in Highly Resistant TB

Slideset Download
Conference Coverage
Reduced doses and/or shorter durations of linezolid are associated with similar efficacy but improved safety.

Released: July 26, 2021

Expiration: July 25, 2022

No longer available for credit.
Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner